Oliver Distler
Oliver Distler is an expert in Rheumatology at University Hospital of Zurich (Switzerland). As of October 2026, ScienceLeadR ranks Oliver Distler in the top 1% of experts worldwide for Arthritis, Scleroderma, Systemic and Lung Diseases, Interstitial. Oliver Distler has authored 1,167 publications, the most recent in 2026, and is an investigator in 23 clinical trials. SLR score: 4,359 (community average: 125). How the SLR is computed.
LeadR Profile
Rheumatology
Subspecialties: Internal Medicine - Pulmonology - Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 1167
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Hallmarks of aging in systemic sclerosis: implications for pathogenesis, multimorbidity, and therapeutic development. PMID 42926811 — sclerosis, comorbidity, aging, multimorbidity, therapeutics, tissues, scleroderma, systemic | EULAR Rheumatol Open | 2026 | 0 |
| The role of inflammation in the pathogenesis of pulmonary fibrosis: mechanisms and treatment implications. PMID 42660607 — lung, fibrosis, respiration, pulmonary fibrosis, therapeutics, lung diseases, lung diseases, interstitial | Eur Respir J | 2026 | 0 |
| Initial treatment strategies and outcomes across haemodynamic thresholds and risk stratification in incident systemic sclerosis-associated pulmonary arterial hypertension: a EUSTAR analysis. PMID 42876376 — sclerosis, hypertension, mortality, arthritis, pulmonary arterial hypertension, therapeutics, scleroderma, systemic | Arthritis Rheumatol | 2026 | 0 |
| Comparative enthesitis burden in psoriatic arthritis vs axial spondyloarthritis: a cross-sectional analysis of the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry. PMID 42856851 — registries, arthritis, psoriatic, cross-sectional studies, pharmaceutical preparations, antirheumatic agents, arthritis, rheumatic diseases, prevalence, sex, smoking, axial spondyloarthritis | EULAR Rheumatol Open | 2026 | 0 |
| Proton pump inhibitor use and long-term outcomes in SSc: a real-life analysis from the EUSTAR database. PMID 42760267 — mortality, phenotype, rheumatic diseases, proton pump inhibitors, proton pumps, lung diseases, interstitial | Rheumatology (Oxford) | 2026 | 0 |
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 8
LeadR Networks
Main global connection map